The WHO has prequalified a second dengue vaccine called TAK-003 The TAK-003 vaccine has been made by the Japanese drug maker Takeda Pharmaceuticals TAK-003 can be administered to children aged 6 to 16 ...
The vaccine, TAK-003, is the second dengue vaccine to be prequalified by WHO. WHO recommends the use of TAK-003 in children aged 6–16 years in settings with high dengue burden and transmission ...
The World Health Organisation (WHO) marked a significant milestone in the global fight against dengue fever with the prequalification of a new vaccine, TAK-003 on May 10, 2024. Developed by Takeda ...
The World Health Organization (WHO) on Wednesday announced that it has prequalified new dengue vaccine. According to WHO, the vaccine, developed by Takeda Pharmaceuticals, received ...
The prequalification of TAK-003 is an important step in the expansion of global access to dengue vaccines, as it is now eligible for procurement by UN agencies including UNICEF. Photo: AFP A new ...
The World Health Organisation (WHO) has prequalified a second vaccine for dengue, made by the Japanese drug maker Takeda Pharmaceuticals. Known as TAK-003, it is a live-attenuated vaccine ...
World Health Organization (WHO) has officially prequalified a new vaccine designed to combat the mosquito-borne viral disease; dengue fever. The WHO announced a news release, that the new vaccine for ...
The World Health Organisation (WHO) marked a significant milestone in the global fight against dengue fever with the prequalification of a new vaccine, TAK-003 on May 10, 2024. Developed by Takeda, ...
(MENAFN- Caribbean News Global) GENEVA, Switaerland – A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue ...
A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it ...